Ceryvyn Therapeutics Ltd Sustainability Reports

Ceryvyn Therapeutics Limited is a clinical-stage biopharmaceutical company focused on translating human biology into targeted treatments for serious progressive conditions like lymphangioleiomyomatosis (LAM).

Sector: Manufacturing

Country: Australia

Exchange: Australian Securities Exchange

LEI: 549300Q5FMFDLP46SF83

5 reports from 2018 to 2025

• Ceryvyn Therapeutics Ltd 2025 Annual Report
• Ceryvyn Therapeutics Ltd 2024 Appendix 4E Preliminary Final Report
• Ceryvyn Therapeutics Ltd 2023 Annual Report
• Ceryvyn Therapeutics Ltd 2021 Appendix 4E Preliminary Final Report
• Ceryvyn Therapeutics Ltd 2018 Appendix 4E Preliminary Final Report